Literature DB >> 2134041

Pathologic features and the classification of interstitial pneumonia of unknown etiology.

M Kitaichi1.   

Abstract

Currently, five types of interstitial pneumonia of unknown etiology or IIP have been described; DAD, UIP, BOOP, DIP and LIP. A summary of the features of clinical course, prognosis and therapeutic effects to steroid hormone treatment of the five types of interstitial pneumonia of unknown etiology or IIP is given in Table 15). Among the previous mentioned 52 open lung biopsy cases of interstitial pneumonia of unknown etiology or IIP, for which an open lung biopsy was necessary for diagnosis, the majority of those cases (81%) was IPF (UIP) while idiopathic BOOP occurred as the second in frequency (13%). These data will help in understanding the clinical outcome and the therapeutic response to steroid hormone treatment in cases of interstitial pneumonia of unknown etiology or IIP, because idopathic UIP is slowly progressive and usually not responsive to steroid while idiopathic BOOP is usually responsive to steroid hormone treatment and may regress even spontaneously. Cases of IPF (UIP) should have revolutional modalities for therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2134041

Source DB:  PubMed          Journal:  Bull Chest Dis Res Inst Kyoto Univ        ISSN: 0009-3378


  6 in total

1.  Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia.

Authors:  Steven K Huang; Scott H Wettlaufer; Cory M Hogaboam; Kevin R Flaherty; Fernando J Martinez; Jeffrey L Myers; Thomas V Colby; William D Travis; Galen B Toews; Marc Peters-Golden
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

2.  Expression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia.

Authors:  Tomoyuki Kakugawa; Hiroshi Mukae; Tomayoshi Hayashi; Hiroshi Ishii; Seiko Nakayama; Noriho Sakamoto; Sumako Yoshioka; Kanako Sugiyama; Mariko Mine; Yohei Mizuta; Shigeru Kohno
Journal:  Respir Res       Date:  2005-06-14

Review 3.  [Interstitial pulmonary diseases].

Authors:  F Brasch
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

4.  Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.

Authors:  Colin J Adams; Karan Chohan; Dmitry Rozenberg; John Kavanagh; Gerhard Greyling; Shane Shapera; Jolene H Fisher
Journal:  Lung       Date:  2021-08-04       Impact factor: 2.584

5.  Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases.

Authors:  Dirk Theegarten; Heike Maria Müller; Francesco Bonella; Jeremias Wohlschlaeger; Ulrich Costabel
Journal:  Diagn Pathol       Date:  2012-11-26       Impact factor: 2.644

6.  [Interstitial lung diseases].

Authors:  K Junker; F Brasch
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.